Fresenius Medical Care Uniquely Positioned to Transform Care for Kidney Failure Patients as Primary Participant in National M...
January 19 2017 - 8:30AM
Business Wire
Centers for Medicare & Medicaid Services
Awards 18 End Stage Renal Disease Seamless Care Organizations to
Fresenius Medical Care, the Largest ESCO Operator in the United
States
Fresenius Medical Care North America, the country’s leading
provider of kidney care products and services, announced today that
the Centers for Medicare & Medicaid Services (CMS) has awarded
it contracts to operate 18 new End Stage Renal Disease Seamless
Care Organizations (ESCOs) across the country. These new ESCOs,
launched January 1, 2017 as Fresenius Seamless Care, are in
addition to the six ESCOs that the company currently operates.
Together, they represent the largest ESCO presence of any kidney
care provider in the nation, demonstrating Fresenius Medical Care’s
continued leadership in transforming the health care system. By
moving beyond traditional methods of care, Fresenius Medical Care’s
dedicated care professionals and its physician partners are working
towards improving patient outcomes for renal patients while
reducing the overall cost of care.
CMS awarded the ESCO contracts under its Comprehensive End-Stage
Renal Disease (ESRD) Care Demonstration Program, the nation’s first
disease-specific shared savings program, which is designed to
identify, test, and evaluate new ways to improve care solely for
Americans with ESRD. Under each ESCO, local nephrologists and
dialysis providers partner to develop an innovative care model
based on highly coordinated, patient-centered care. Patients will
benefit from these innovations in care delivery while retaining
their full Medicare benefits and the freedom to choose their
providers.
“We are excited for the opportunity to work with CMS on this
important initiative and we are proud to have now been awarded 18
ESCOs in markets across the country,” said Bill Valle, Fresenius
Medical Care North America’s Chief Executive Officer. “More than
ever, chronically ill patients such as those suffering from kidney
failure deserve coordinated and integrated care. By working closely
with our physician partners, our network of providers and care
coordinators have demonstrated the ability to improve our patients’
health outcomes and reduce costs for the system. This announcement
is further validation of the commitment that our dedicated doctors,
nurses, technicians, social workers, pharmacists and care
coordinators put into action to improve the quality of life of
every patient, every day.”
The foundation of each Fresenius Seamless Care ESCO is the
collaboration of doctors, local care providers and Care Navigation
Unit (CNU), a team of specialized dialysis nurses and service
coordinators who provide 24/7 patient support and care management
services. By focusing on the unique clinical and psycho-social
needs of each patient, the CNU can anticipate issues before they
arise and help patients, their families and their providers respond
more quickly as they happen.
“The Fresenius Seamless Care ESCO expands the traditional role
of the dialysis and nephrology providers to deliver comprehensive
care both in and outside of the dialysis clinic,” explained William
McKinney, President of Fresenius Medical Care North America’s
Integrated Care Group. “It’s a model that we’ve proven can improve
health outcomes for the ESRD patient. Through rigorous monitoring
and appropriate intervention, the CNU has been able to help
patients and their providers reduce hospital admissions by up to
20.3% and readmissions by up to 27.8% in ESRD populations.”
Fresenius Medical Care’s significant expansion of its ESCO
presence throughout the country builds upon a track record of
successfully improving patient care. Each year since 2006, the
company has helped patients live longer and spend less time in the
hospital, improving mortality rates of its dialysis patients and
lowering the average time spent in a hospital setting by
two-and-a-half days.
About Fresenius Medical Care North
AmericaFresenius Medical Care North America is the premier
health care company focused on providing the highest quality care
to people with renal and other chronic conditions. Through its
industry-leading network of dialysis centers, outpatient cardiac
and vascular labs, and urgent care centers, as well as the
continent’s largest practice of hospitalist and post-acute
providers, Fresenius Medical Care North America provides
coordinated health care services at pivotal care points for
hundreds of thousands of chronically ill customers. As the world’s
largest fully vertically integrated renal company, it offers
specialty pharmacy and laboratory services, and manufactures and
distributes the most comprehensive line of dialysis equipment,
disposable products, and renal pharmaceuticals. For more
information, visit www.FMCNA.com.
About Fresenius Health PartnersFresenius Health
Partners is the insurance component of Fresenius Medical Care North
America specializing in intensive care coordination and disease
management services for individuals with Chronic Kidney Disease or
End Stage Renal Disease. Rapidly emerging as the recognized leader
in providing comprehensive healthcare coverage for renal patients,
Fresenius Health Partners works with government payors, private
health plans and accountable care organizations to improve the
health and outcomes of renal patients while at the same time
reducing the total cost of their care. For more information on
Fresenius Health Partners’ programs, including the Fresenius
Seamless Care ESCOs, visit www.freseniushealthpartners.com.
The statements contained in this document are solely those of
the authors and do not necessarily reflect the views or policies of
CMS. The authors assume responsibility for the accuracy and
completeness of the information contained in this document.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170119005195/en/
Fresenius Medical Care North AmericaJon Stone,
781-392-4680Jonathan.d.stone@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Sep 2023 to Sep 2024